<p>Oaktree Acquisition Corp. III Life Sciences（納斯達克代碼：OACC - 獲取免費報告）的股價在週三上漲了 0.3%。該股交易最高達到 10.60 美元，最後交易價為 10.60 美元。在午盤交易中，共成交 1,053 股，較平均交易量 58,164 股下降了 98%。該股此前收盤價為 10.57 美元。</p>
<h2>分析師評級變動</h2>
<p>另外，Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Oaktree Acquisition Corp. III Life Sciences 的 “賣出（d-）” 評級。一位研究分析師對該股給予了賣出評級，根據 MarketBeat 的數據，該股目前的平均評級為 “賣出”。</p>
<p><strong>查看我們對 OACC 的最新分析</strong></p>
<h2>Oaktree Acquisition Corp. III Life Sciences 股票表現</h2>
<p>該公司的 50 日移動平均價格為 10.58 美元，200 日移動平均價格為 10.51 美元。</p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者最近對該公司的持倉進行了調整。Driehaus Capital Management LLC 在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值 918 萬美元。Lighthouse Investment Partners LLC 在第二季度將其在 Oaktree Acquisition Corp. III Life Sciences 的持股增加了 88.9%。Lighthouse Investment Partners LLC 目前擁有該公司 850,000 股股票，價值 8,882,000 美元，此前在上一季度又購買了 400,000 股。Linden Advisors LP 在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 612 萬美元。高盛集團在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 541.7 萬美元。最後，Moore Capital Management LP 在第二季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 550.2 萬美元。</p>
<h2>關於 Oaktree Acquisition Corp. III Life Sciences</h2>
<p>（獲取免費報告）</p>
<p>Oaktree Acquisition Corp. III Life Sciences 是一家空白支票公司，成立的目的是進行合併、資本股票交換、資產收購、股票購買、重組或與一家或多家企業進行類似的商業組合。該公司成立於 1995 年，總部位於加利福尼亞州洛杉磯。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票超過 Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 個適合股息增長投資者的折扣機會</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>什麼是股息挑戰者？</li>
<li>3 個理由説明 Casey’s General Stores 將繼續上漲</li>
<li>交易暫停解釋</li>
<li>黃金交叉警報：3 只具有重大上漲潛力的股票</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oaktree Acquisition Corp. III Life Sciences 嗎？</h2>
<p>在考慮 Oaktree Acquisition Corp. III Life Sciences 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而 Oaktree Acquisition Corp. III Life Sciences 並不在名單上。</p>
<p>雖然 Oaktree Acquisition Corp. III Life Sciences 目前在分析師中被評為賣出，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OACC

<p>Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) 的股價上漲了 0.3%，達到 10.60 美元，儘管 Weiss Ratings 給予了 “賣出” 評級。交易量明顯低於平均水平。機構投資者已調整其持倉，Driehaus Capital Management 和 Lighthouse Investment Partners 進行了顯著的購買。分析師建議其他股票可能是更好的投資選擇</p>

<p>Shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Get Free Report) shot up 0.3% on Wednesday . The stock traded as high as $10.60 and last traded at $10.60. 1,053 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 58,164 shares. The stock had previously closed at $10.57.</p>
<div class="lb-trans"><p>Oaktree Acquisition Corp. III Life Sciences（納斯達克代碼：OACC - 獲取免費報告）的股價在週三上漲了 0.3%。該股交易最高達到 10.60 美元，最後交易價為 10.60 美元。在午盤交易中，共成交 1,053 股，較平均交易量 58,164 股下降了 98%。該股此前收盤價為 10.57 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Oaktree Acquisition Corp. III Life Sciences 的 “賣出（d-）” 評級。一位研究分析師對該股給予了賣出評級，根據 MarketBeat 的數據，該股目前的平均評級為 “賣出”。</p>
</div><p><strong>View Our Latest Analysis on OACC</strong></p>
<div class="lb-trans"><p><strong>查看我們對 OACC 的最新分析</strong></p>
</div><h2>Oaktree Acquisition Corp. III Life Sciences Stock Performance</h2>
<div class="lb-trans"><h2>Oaktree Acquisition Corp. III Life Sciences 股票表現</h2>
</div><p>The company's 50 day moving average price is $10.58 and its 200-day moving average price is $10.51.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均價格為 10.58 美元，200 日移動平均價格為 10.51 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the company. Driehaus Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $9,180,000. Lighthouse Investment Partners LLC lifted its holdings in Oaktree Acquisition Corp. III Life Sciences by 88.9% during the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company's stock valued at $8,882,000 after purchasing an additional 400,000 shares during the last quarter. Linden Advisors LP bought a new position in Oaktree Acquisition Corp. III Life Sciences during the first quarter worth about $6,120,000. Goldman Sachs Group Inc. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $5,417,000. Finally, Moore Capital Management LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at approximately $5,502,000.</p>
<div class="lb-trans"><p>一些機構投資者最近對該公司的持倉進行了調整。Driehaus Capital Management LLC 在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值 918 萬美元。Lighthouse Investment Partners LLC 在第二季度將其在 Oaktree Acquisition Corp. III Life Sciences 的持股增加了 88.9%。Lighthouse Investment Partners LLC 目前擁有該公司 850,000 股股票，價值 8,882,000 美元，此前在上一季度又購買了 400,000 股。Linden Advisors LP 在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 612 萬美元。高盛集團在第一季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 541.7 萬美元。最後，Moore Capital Management LP 在第二季度購買了 Oaktree Acquisition Corp. III Life Sciences 的新股份，價值約 550.2 萬美元。</p>
</div><h2>About Oaktree Acquisition Corp. III Life Sciences</h2>
<div class="lb-trans"><h2>關於 Oaktree Acquisition Corp. III Life Sciences</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.</p>
<div class="lb-trans"><p>Oaktree Acquisition Corp. III Life Sciences 是一家空白支票公司，成立的目的是進行合併、資本股票交換、資產收購、股票購買、重組或與一家或多家企業進行類似的商業組合。該公司成立於 1995 年，總部位於加利福尼亞州洛杉磯。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 discounted opportunities for dividend growth investors</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>What Are Dividend Challengers?</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>Trading Halts Explained</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Oaktree Acquisition Corp. III Life Sciences</li>
<li>5 個適合股息增長投資者的折扣機會</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>什麼是股息挑戰者？</li>
<li>3 個理由説明 Casey’s General Stores 將繼續上漲</li>
<li>交易暫停解釋</li>
<li>黃金交叉警報：3 只具有重大上漲潛力的股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oaktree Acquisition Corp. III Life Sciences Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oaktree Acquisition Corp. III Life Sciences 嗎？</h2>
</div><p>Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oaktree Acquisition Corp. III Life Sciences 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而 Oaktree Acquisition Corp. III Life Sciences 並不在名單上。</p>
</div><p>While Oaktree Acquisition Corp. III Life Sciences currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oaktree Acquisition Corp. III Life Sciences 目前在分析師中被評為賣出，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oaktree Acquisition Corp III Life Sciences (NASDAQ:OACC) 股價上漲 0.3% - 仍然是買入的好時機嗎？